Pathogenesis and medical management of cystinuria

Seminars in Nephrology

Volumn 16, Issue 5, 1996, Pages 435-447

  Sakhaee, Khashayar ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCILLAMINE; CAPTOPRIL; CHELATING AGENT; CITRATE POTASSIUM; GLUTAMINE; PENICILLAMINE; TIOPRONIN;

AMINO ACID TRANSPORT; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL EXAMINATION; CYSTINURIA; DIET THERAPY; FLUID THERAPY; HUMAN; INTESTINE ABSORPTION; KIDNEY TUBULE ABSORPTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UROLITHIASIS;

CHELATING AGENTS; CYSTINURIA; GLUTAMINE; HUMANS; PROGNOSIS;

EID: 0029770703     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Segal S, Thier S: Cystinuria, in Scriver CR, Beandet AZ, Sly WS (eds): The metabolic basis of inherited disease. New York, NY, McGraw Hill, 1989, pp 2479-2496
2. Milne MD, Asatoor AM, Edwards KDG, et al: The intestinal absorption defect in cystinuria. Gut 2:323-337, 1961
3. Thier SO, Segal S, Fox M, et al: Cystinuria: Defective intestinal transport of dibasic amino acids and cystine. J Clin Invest 44:442-448, 1965
4. Pak CYC, Fuller C: Assessment of cystine solubility and heterogeneous nucleation. J Urol 129:1066-1070, 1983
5. Scriver CR: Cystinuria. N Engl J Med 315:1155-1157, 1983
6. SenLee W, Wells RG, Sabbag RV, et al: Cloning and chromosomal location of a human kidney cDNA involved in cystine, dibasic and neutral amino acid transport. J Clin Invest 91:1959-1963, 1993
7. Bertran J, Werner A, Chillaron J, et al: Expression cloning of a human renal cDNA that induces high affinity transport of L-cystine shared with dibasic amino acids in xenopus oocytes. J Biol Chem 268:14842-14849, 1993
8. Wright EM: Cystinuria defect expresses itself. Nature Genetics 6:328-329, 1994
9. Calonge MJ, Gasparini P, Chillaron J, et al: Cystinuria caused by mutations in rBAT, a gene involved in the transport of cystine. Nature Genetics 6:420-425, 1994
10. Wollaston WH: On cystic oxide. A new species of urinary calculus. Trans R Soc Lond 100:223-230, 1810
11. Berzellius J: Calculus urinaires. Traite Chem 7:424, 1833
12. Friedman E: Derkrieslaufdes Schwefelsinder Organischen. Nature Ergeh Phyiol 1:15, 1902
13. Garrod AE: Inborn errors of metabolism. Lancet 2 (Lecture I, pp 1; Lecture II, pp 73; Lecture III, pp 142; Lecture IV, pp 214), 1908
14. Yeh HL, Frankl W, Dunn MS, et al: The urinary excretion of amino acids by cystinuric subjects. Am J Med Sci 214:507-512, 1974
15. Dent CC, Rose GA: Amino acid metabolism in cystinuria. Quary J Med New Series 20:205-219, 1951
16. Crawhall JC, Scowen EF, Watts RWE: Effect of dpenicillamine in cystinuria. BMJ 1:588-590, 1963
17. DeFronzo RA, Thier SO: Renal tubular defect in phosphate and amino acid transport, in Andreoli TE, Hoffman JF, Fanestil DD (eds): Physiology of Membrane Disorders. New York, NY, Plenum Press, 1978, pp 1041-1061
18. Cusworth DC, Dent CE: Renal clearance of amino acids in normal adults and in patients with amino aciduria. Biochem J 74:550-561, 1960
19. Schafer JA, Watkins ML: Transport of L-cystine in isolated perfused proximal straight tubules. Pflugers Arch 401:143-151, 1984
20. Silbemagl S, Deetjen P: The tubular reabsorption of L-cystine and L-cysteine. A common transport system with L-arginine or not? Pflugers Arch 337:227-284, 1972
21. Volkl H, Silbemagl S: Mutual inhibition of L-cystine/ L-cysteine and other neutral amino acids during tubular reabsorption. A microperfusion study in rat kidney. Pflugers Arch 395:190-195, 1982
22. Volkl H, Silbemagl S: Re-examination of the interplay between dibasic amino acids and L-cystine/L-cysteine during tubular reabsorption. Pflugers Arch 395:196-200, 1982
23. Busse D, Bartel H: Transport of L-cystine and L-arginine in brush border vesicles derived from rabbit kidney cortex. Renal Physiol 2:152-153, 1980
24. McNamara PD, Pepe LM, Segal S: Cystine uptake by renal brush vesicles. Biochem J 194:443-449, 1981
25. Silbemagl S: Amino acids and oligopeptides, in Seldin DW, Giebisch G (eds): The Kidney: Physiology and Pathophysiology. New York, NY, Raven Press, 1985, pp 1677-1701
26. Crawhall JC, Scowen EF, Thompson CS: The renal clearance of amino acids in cystinuria. J Clin Invest 46:1162-1171, 1967
27. Frimpter GW, Horwith M, Furthe E, et al: Inulin and endogenous amino acids renal clearance in cystinuria: Evidence for tubular secretion. J Clin Invest 41:281-288, 1962
28. Doolan PD, Harper HA, Hutchin ME, et al: Renal clearance of lysine in cystinuria, pathogenesis and management of this abnormality. Am J Med 23:416-425, 1957
29. Rosenberg L, Downing S, Segal S: Competitive inhibition of dibasic amino acid transport in rat kidney. J Biol Chem 237:2265-2270, 1962
30. Segal S, Smith I: Delineation of cystine and cysteine transport systems in rat kidney cortex by developmental patterns. Proc Natl Acad Sci USA 63:926-933, 1969
31. Fox M, Thier SO, Rosenberg LE, et al: Evidence against a single transport defect in cystinuria. N Engl J Med 270:556-561, 1964
32. Silbemagl S, Foulkes EC, Deetjeh D: Renal transport of amino acids. Rev Physiol Biochem Pharmacol 74:105-167, 1957
33. Forrnan J, Hwang SM, Segal S: Transport interactions of cystine and dibasic amino acids in isolated rat renal tubules. Metabolism 29:53-61, 1980
34. Segal S, McNamara PD, Pepe LM: Transport interaction of cystine and dibasic amino acids in renal brush border vesicles. Science 197:169-171, 1977
35. Milne MD, Crawford MA, Giaro CB, et al: The metabolic disorder in Hartnup disease. Q J Med 29:407-421, 1960
36. Rosenberg LE, Dowing S, Durant JL, et al: Cystinuria: Biochemical evidence for three genetically distinct diseases. J Clin Invest 45:365-371, 1966
37. Thier SO, Halperin EC: Cystinuria, in Coe FL (ed): Nephrolithiasis. New York, NY, Churchill Llivingstone, 1980, pp 208-230
38. Levy H: Genetic screening, in Herns H, Hirschorn K (eds): Advances in Human Genetics. New York, NY, Plenum Press, 1973, pp 1-82
39. Kelly S: Cystinuria genotypes predicted from excretion patterns. Am J Med Genet 2:175-190, 1978
40. Dent CE, Senior B: Studies on the treatment of cystinuria. Br J Urol 27:317-322, 1955
41. Ettinger B, Kolb FO: Factors involved in crystal formation in cystinuria: In vivo and in vitro crystallization dynamics and a simple, quantitative colorimetric assay for cystine. J Urol 106:106-110, 1971
42. Sakhaee K, Poindexter JR, Pak CYC: The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. J Urol 141:819-821, 1989
43. Vergis JG, Walker BR: Cystinuria, hyperuricemia and uric acid nephrolithiasis. Nephron 7:577-579, 1970
44. Linari F, Marangella M, Malfi B, et al: Hyperuricemia and cystinuria, in Watts RWE, DeBruyn CHNM (eds): Advances in Experimental Medicine and Biology. New York, NY, Plenum Press, 1980, pp 135-39
45. Thier SO, Segal S: Cystinuria, in Stanbury JB, Wyngaarden JB, Fredrickson DS (eds): Metabolic Basis of Inherited Disease. New York, NY, McGraw Hill, 1972, pp 1504-1519
46. Scriver CR, Whelan DT, Claw CL, et al: Cystinuria: Increased prevalence in patients with mental disease. N Engl J Med 283:783-786, 1970
47. Brand E, Harris MM, Billon S: Cystinuria: Excretion of a cystine complex which decomposes in the urine with the liberation of free cystine. J Biol Chem 86:315-331, 1930
48. Kolb FO, Earll JM, Harper HA: "Disappearance" of cystinuria in a patient treated with prolonged low methionine diet. Metabolism 16:378-381, 1967
49. Pak CYC: Cystine lithiasis, in Resnick MI, Pak CYC (eds): Urolithiasis. A Medical and Surgical Reference. Philadelphia, PA, Saunders, 1990, pp 133-143
50. Jaeger P, Portmann L, Saunders A, et al: Anticystinuric effects of glutamine and of dietary sodium restriction. N Engl J Med 315:1120-1123, 1986
51. Sakhaee K, Nicar M, Hill K, et al: Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salt. Kidney Int 24:348-352, 1983
52. Miyagi K, Nakada S, Oshiro D: Effect of glutamine on cystine excretion in a patient with cystinuria. N Engl J Med 301:196-198, 1979
53. Vanderberg K, Jones JD, Wilson DM, et al: Glutamine therapy of cystinuria. Invest Urol 18:155-157, 1980
54. Sloand JA, Izzo JL: Captopril reduces urinary cystine excretion in cystinuria. Arch Intern Med 147:1409-1412, 1987
55. Milliner MD: Cystinuria. Endocrinol Metab Clin North Am 19:889-907, 1990
56. Perazella MA, Buller GK: Successful treatment of cystinuria with captopril. Am J Kidney Dis 21:504-507, 1993
57. Dahlberg PJ, Vandenberg CJ, Kurtz SB, et al: Clinical features and management of cystinuria. Mayo Clin Proc 52:533-542, 1977
58. Halperin E, Thier SO, Rosenberg LE: The use of penicillamine in cystinuria: Efficacy and untoward reactions. Yale J Biol Med 54:439-446, 1981
59. Pak CYC: Alpha-mercaptopropionylglycine for the prevention of cystinuria, in Pak CYC (guest ed), Vessell ES, Lomax P (eds): Pharmacological Treatment of Endocrinopathies: Bone Disease, Kidney Stones and Related Disorders. Basel, Switzerland, Karger, 1990, pp 49-62
60. Pak CYC, Fuller K, Sakhaee K, et al: Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol 136:1003-1008, 1986
61. Kashiwazaki S, Shiokawa Y: Bucillamine: A new immunomodulator. Int Med J Immunotherapy 3:(1)1-6, 1987
62. Koide T, Yamaguchi S, Utsonomiya M, et al: in: A new therapeutic agent for cystinuria. VII Int. Symposium on Urolithiasis. Cairns, Australia, August, 1992, p 168